https://eldorado.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=4619514&GUID=A3673706-0F3A-42DD-9BC0-6F5FE85DE426Legistar15https://eldorado.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=4619514&GUID=A3673706-0F3A-42DD-9BC0-6F5FE85DE426A3673706-0F3A-42DD-9BC0-6F5FE85DE426-2020-09-03-22-40-18Title: Health and Human Services Agency recommending the Board: 1) Approve and authorize the Chair to sign Non-Financial Agreement for Services 4604 with Assurex Health Inc., doing business as (dba) Myriad Neuroscience, for the provision of genetic testing to support medication choices, for a perpetual term that commences upon execution; 2) Approve and authorize the Chair to sign Agreement for Services 4483 with Assurex Health Inc., doing business as (dba) Myriad Neuroscience, for the provision of genetic testing to support medication choices, with a maximum contractual obligation of $100,000, and for a term effective upon execution through June 30, 2023; 3) Make findings in accordance with County Ordinance 3.13.030 that (B) “Specialty skills and qualifications not expressly identified in County classifications are involved in the performance of the work.” Therefore, it is appropriate to contract with Myriad Neuroscience for services provided under these Agreements 4604 and 4483; and 4) Authorize the Purchasing Agent, or designee, to execute further documents relating to Agreement foThu, 03 Sep 2020 22:40:18 GMT